Hematologic Malignancies


The OSUCCC – James is home to an internationally renowned center for hematologic malignancy treatment and research. Transdisciplinary teams of hematologists, oncologists, mid-level practitioners, researchers, nurses and other experts specialize in distinct hematologic malignancies, including:

Ohio State’s distinguished history in leukemia research began in 1958, when Dr. Bertha Bouroncle identified the cell responsible for hairy cell leukemia, a rare chronic leukemia.

Today, millions of dollars in research grants, including multiple grants from the National Cancer Institute and from the Leukemia and Lymphoma Society, support OSUCCC – James studies into how blood cancers develop and into identifying promising investigational treatments.

The OSUCCC – James is also one of only two comprehensive leukemia centers in the nation to have an NCI Specialized Program of Research Excellence (SPORE) grant.

Dozens of clinical trials under way at the OSUCCC – James enable us to provide patients with the latest advances in detecting and treating hematologic malignancies.

Acute Myeloid Leukemia

The OSUCCC – James has an international reputation for clinical research in acute myeloid leukemia at the chromosomal, gene and molecular levels. Our world-renowned experts have contributed to World Health Organization diagnostic and treatment guidelines.

Read More

Blood & Marrow Transplantation

The mlood and marrow transplant (BMT) program at the OSUCCC – James has earned international recognition for advancements in treating cancer.

Read More

Chronic Lymphocytic Leukemia

At the OSUCCC – James, research for CLL and other forms of leukemia occurs within the Leukemia Research Program, a program that comprises many disciplines and the collaboration of many scientists — including 42 investigators from four colleges and 11 academic departments at Ohio State.

Read More

Lymphoma

The OSUCCC – James has a strong experimental therapeutics and clinical research focus on B- and T-cell lymphomas, including rare lymphomas such as adult T-Cell lymphoma. A particularly exciting and promising area of research investigates vaccine and immunotherapies for Epstein-Barr-virus-related post-transplant lymphoma.

Read More

Multiple Myeloma

The OSUCCC – James has a team of physicians who specialize in diagnosing and treating MM. With diagnostic, research and treatment areas under one roof, these experts can quickly translate scientific advances to innovative patient care that extends lives and offers hope for patients and families.

Read More

Search for Clinical Trials

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program

OR

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Find a Scientific Publication